Dr Reddy's launches oncology injection in US
Generics drugs maker Dr Reddy's Laboratories on Tuesday said it has launched Zoledronic Acid injection 4mg/5ml in the US market following approval by the US Food and Drugs Administration.
March 05, 2013 / 16:01 IST
Moneycontrol Bureau
Generic drugs maker Dr Reddy's Laboratories on Tuesday said it has launched Zoledronic Acid injection 4mg/5ml in the US market following approval by the US Food and Drugs Administration.The injection is a copy of Novartis AG's Zometa, a drug used to strengthen bones in cancer patients.Don't Miss: Natco Pharma soars 12% on Nexavar case winDr Reddy's Zoledronic Acid injection is available in a single use vial of concentrate, it said.Dr Reddy's shares were up over 1 percent at Rs 1,783.75 on NSE in morning trade. Also Read: Bears with inside info hammer NHPC shares 32% in 3 sessions Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
